— Know what they know.
Not Investment Advice
Also trades as: 2784.T (JPX) · $vol 7M · ARHCF (OTC) · $vol 0M

ALFRY OTC

Alfresa Holdings Corporation
1W: +0.0% 1M: -1.6% 3M: -3.4% YTD: -12.0% 1Y: -16.7% 3Y: -0.7% 5Y: -42.9%
$13.55
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Distribution · Tech Score Sell · Power 47 · $2.5B mcap · 167M float · 0.0001% daily turnover · Short 45% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$2.5B
52W Range11.39-16.81
Volume100
Avg Volume142
Beta-0.15
Dividend$0.44
Analyst Ratings
No analyst coverage
Company Info
CEORyuji Arakawa
Employees12,525
SectorHealthcare
IndustryMedical - Distribution
IPO Date2018-01-03
Ote Center Building
Tokyo, TY 100-0004
JP
81 3 5219 5100
About Alfresa Holdings Corporation

Tokyo, Japan-based Alfresa Holdings Corporation, established in 2003, is a diversified entity operating domestically and internationally within the healthcare industry. The company's core activities encompass the production, wholesale distribution, marketing, and global trade of pharmaceuticals, diagnostic agents, and medical equipment. Alfresa operates through distinct wholesale divisions, including an ethical pharmaceuticals segment that supplies hospitals, clinics, and pharmacies with essential diagnostic reagents, medical devices, and prescription drugs. Another division specializes in self-medication products, delivering over-the-counter medicines, health foods, and nutritional supplements to drugstores and pharmacies. Beyond distribution, Alfresa is actively involved in manufacturing and commercializing active pharmaceutical ingredients, finished drug products, diagnostic reagents, and medical devices, alongside offering contract manufacturing services for pharmaceuticals. Additionally, its medical-related ventures include managing dispensing pharmacies and other ancillary healthcare services.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms